QuidMetrics
Contact us

Thank you for visiting QuidMetrics.

We welcome your feedback, news tips and press releases. Get in touch with the right team below.

General enquiries, news tips and press releases[email protected]

Corrections and editorial enquiries[email protected]

Click here for more details

Boots launches medical cannabis prescribing service online

The pharmacy chain becomes the first on the British high street to offer prescriptions for medical cannabis through an online service.

Boots has announced it will begin prescribing medical cannabis, becoming the first UK high street pharmacy to offer such a service. The online offering, called SureLeaf, will be available to patients aged 25 and older who have eligible conditions including chronic pain, anxiety and insomnia. The chain is launching the service alongside a research programme with the University of Nottingham to examine patient outcomes, prescribing practices and experience in treating chronic pain.

Patients will begin with an online assessment, after which a clinical team will review their suitability. Those approved will then have a video consultation with a consultant. Boots said any prescription would be independently reviewed by a multidisciplinary clinical team, including a second independent consultant, before treatment starts. The pharmacy stressed that patients must first have tried conventional treatments without success before being considered for medical cannabis, and that those prescribed would be regularly reviewed.

Jamie Kerruish, Boots' chief healthcare officer, said the service aims to help people who live with ongoing pain and for whom conventional treatments do not provide adequate relief. He noted that such pain can significantly affect daily life, including work, sleep and time with family. Dr David Gwynne, medical director of Boots' online service, said medical cannabis is not appropriate for everyone and that strong clinical safeguards and specialist oversight are built into SureLeaf at every stage.

The prescription of cannabis-derived medicines was legalised in 2018 following a case involving a young boy from Northern Ireland with severe epilepsy. Currently, only people with rare forms of epilepsy, certain side-effects of chemotherapy, and certain multiple sclerosis symptoms can access medical cannabis on the NHS. Private clinics have been prescribing the medicines for years, treating patients with various psychiatric and neurological conditions beyond those covered by the NHS.

Research published this year by universities in Sydney, Brisbane, Melbourne and Bath found very little evidence that cannabis was effective in treating anxiety, anorexia nervosa, psychotic disorders, post-traumatic stress disorder or opioid use disorder. However, the researchers found some evidence that medical cannabis products could reduce dependence on cannabis, relieve Tourette syndrome symptoms and help insomniacs sleep better.

For UK patients struggling with chronic pain or other eligible conditions, Boots' service offers access to medical cannabis prescriptions through a high street pharmacy for the first time, though treatment will only be considered where clinically appropriate and after conventional options have been exhausted.